// App-Quantinova.ai

Sa1287 : Potential Cost Savings Associated With Timely Fecal Microbiota Transplantation (FMT) for Recurrent Clostridium difficile Infection (RCDI)

Researchers

Presenter

  • Dina Kao

Principal Investigators

  • N/A

Medical Centers

  • Univ. of Alberta, Edmonton, Alberta, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Clostridium difficile infection

Biomarkers

  • N/A

Drug/Treatment

  • Fidaxomicin

  • vancomycin capsule

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved